XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||
Earning before tax | -395.95%-135.73M | -82.02%18.02M | ---27.37M | -56.02%100.23M | 56.20%227.88M | --145.89M |
Profit adjustment | ||||||
Interest (income) - adjustment | 66.96%-1.86M | 36.99%-9.03M | ---5.62M | 31.10%-14.33M | -145.40%-20.8M | ---8.47M |
Attributable subsidiary (profit) loss | ---- | 43.97%-446K | ---307K | -45.26%-796K | 43.91%-548K | ---977K |
Impairment and provisions: | --336K | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | --336K | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | 122.32%142.25M | 436.16%75M | --63.98M | -47.58%13.99M | 39.43%26.69M | --19.14M |
-Other fair value changes | 122.32%142.25M | 436.16%75M | --63.98M | -47.58%13.99M | 39.43%26.69M | --19.14M |
Asset sale loss (gain): | -102.00%-44K | --6.78M | --2.2M | ---- | -96.37%162K | --4.46M |
-Loss (gain) from sale of subsidiary company | ---- | --6.48M | --2M | ---- | -97.31%112K | --4.16M |
-Loss (gain) on sale of property, machinery and equipment | -122.45%-44K | --300K | --196K | ---- | -82.94%50K | --293K |
Depreciation and amortization: | 13.49%14.98M | -7.88%27.43M | --13.2M | 5.37%29.78M | 34.82%28.26M | --20.96M |
-Amortization of intangible assets | 14.29%136K | 13.33%255K | --119K | -73.78%225K | 90.67%858K | --450K |
Financial expense | 19.30%3.28M | 0.86%5.77M | --2.75M | 16.13%5.72M | 50.70%4.92M | --3.27M |
Special items | ---- | 99.54%-84K | ---29K | -8,432.08%-18.09M | 82.32%-212K | ---1.2M |
Operating profit before the change of operating capital | -52.44%23.21M | 5.96%123.45M | --48.8M | -56.26%116.51M | 45.50%266.36M | --183.07M |
Change of operating capital | ||||||
Accounts receivable (increase)decrease | -46.86%-8.41M | 18.83%-3.13M | ---5.73M | -116.09%-3.86M | 121.34%23.99M | --10.84M |
Accounts payable increase (decrease) | -291.32%-49.37M | 962.63%26.27M | ---12.62M | 88.40%-3.05M | -148.24%-26.24M | --54.4M |
prepayments (increase)decrease | -396.88%-24.65M | -115.39%-1.36M | --8.3M | 173.08%8.85M | -266.15%-12.11M | --7.29M |
Cash from business operations | -252.74%-59.21M | 22.60%145.22M | --38.77M | -52.99%118.45M | -1.41%251.99M | --255.6M |
Other taxs | 42.98%-4.41M | 5.46%-21.86M | ---7.74M | 63.47%-23.12M | -26.28%-63.29M | ---50.12M |
Net cash from operations | -305.05%-63.62M | 29.40%123.36M | --31.03M | -49.48%95.33M | -8.16%188.71M | --205.48M |
Cash flow from investment activities | ||||||
Interest received - investment | -74.99%2.4M | -0.71%12.43M | --9.59M | -34.03%12.52M | 123.91%18.97M | --8.47M |
Decrease in deposits (increase) | ---- | ---- | ---- | -166.67%-1M | --1.5M | ---- |
Sale of fixed assets | 945.45%345K | -87.56%83K | --33K | 65.92%667K | 1,082.35%402K | --34K |
Purchase of fixed assets | 48.57%-866K | -55.72%-7.1M | ---1.68M | 26.65%-4.56M | -128.40%-6.22M | ---2.72M |
Purchase of intangible assets | -2.27%-45K | -65.91%-73K | ---44K | 27.87%-44K | -205.00%-61K | ---20K |
Sale of subsidiaries | ---- | ---2.02M | ---2.02M | ---- | --2.67M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | 3,377.52%13.46M | --387K |
Recovery of cash from investments | -97.27%2M | 256.27%76.21M | --73.23M | -65.22%21.39M | -26.08%61.5M | --83.2M |
Cash on investment | -580.00%-6.8M | 96.75%-2.5M | ---1M | -259.96%-77M | 65.22%-21.39M | ---61.5M |
Other items in the investment business | -92.05%14.4M | 5,549.37%233.88M | --181.16M | 103.50%4.14M | -24.16%-118.33M | ---95.3M |
Net cash from investment operations | -95.59%11.43M | 808.40%310.91M | --259.26M | 7.59%-43.89M | 29.59%-47.49M | ---67.45M |
Net cash before financing | -117.98%-52.19M | 744.18%434.27M | --290.29M | -63.57%51.44M | 2.31%141.21M | --138.03M |
Cash flow from financing activities | ||||||
New borrowing | -28.34%79.7M | 11.94%160.72M | --111.22M | 130.84%143.58M | 214.13%62.2M | --19.8M |
Refund | 72.60%-69.5M | -224.65%-283.35M | ---253.65M | -10.74%-87.28M | ---78.82M | ---- |
Issuing shares | -74.37%139.12M | 436.85%542.86M | --542.86M | --101.12M | ---- | ---- |
Interest paid - financing | -19.30%-3.28M | -0.86%-5.77M | ---2.75M | -16.13%-5.72M | -50.70%-4.92M | ---3.27M |
Dividends paid - financing | 66.96%-60.2M | -32.83%-198.39M | ---182.21M | -917.37%-149.35M | -22.33%-14.68M | ---12M |
Absorb investment income | -62.02%245K | --645K | --645K | ---- | -83.05%200K | --1.18M |
Issuance expenses and redemption of securities expenses | --3.27M | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -195.00%-1.18M | ---86.18M | ---400K | ---- | ---- | ---600K |
Net cash from financing operations | -64.17%75.48M | 798.87%111.51M | --210.66M | 67.57%-15.96M | -673.25%-49.2M | ---6.36M |
Effect of rate | -74.66%930K | -73.79%369K | --3.67M | 15,744.44%1.41M | 98.80%-9K | ---748K |
Net Cash | -95.35%23.29M | 1,437.91%545.77M | --500.95M | -61.43%35.49M | -30.12%92.01M | --131.67M |
Begining period cash | 140.29%935.44M | 10.47%389.3M | --389.3M | 35.33%352.4M | 101.11%260.4M | --129.48M |
Cash at the end | 7.35%959.66M | 140.29%935.44M | --893.92M | 10.47%389.3M | 35.33%352.4M | --260.4M |
Cash balance analysis | ||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.